Fig. 3: Genomic characterisation of plasmacytoid urothelial carcinoma.

Oncoprint of 33 plasmacytoid urothelial carcinoma cases. Left, the prevalence of alterations in genes commonly altered in urothelial carcinoma, not otherwise specified, per The Cancer Genome Atlas analysis. Right, the prevalence of alterations in selected DNA damage response genes.